They found that NOD-SCID mice receiving splenocytes from 6-week-old NOD mice developed diabetes 11 weeks after transfer, and those receiving diabetogenic CD4+CD25−CD62L− T cells from mice of the same age developed disease 5 weeks after transfer. This evidence concerns the gene CD4 and diabetes mellitus.